%PDF-1.3
%
1 0 obj
<>>>/BBox[0 0 612 792]/Length 54>>stream
xs
w3T0WI2P0T5T0P06T04S @$P5 d
k
endstream
endobj
3 0 obj
<>>>/BBox[0 0 612 792]/Length 54>>stream
xs
w3T0WI2P0T5T0P06T04S @$P5 d
k
endstream
endobj
5 0 obj
<>stream
Acrobat Distiller 8.1.0 (Windows); modified using iText 4.2.0 by 1T3XT
Arbortext Advanced Print Publisher 9.0.114/W
2018-05-30T18:51:58-07:00
2017-12-12T02:29:23+05:30
application/pdf
LRB-2017-29033-sr-ver9-Rockson_2P 315..316
uuid:cf29ca3f-d21b-4275-b5d5-5cc521d8be57
uuid:3aca7fe9-f274-475f-ae55-1b5721be49da
endstream
endobj
6 0 obj
<>stream
x+ |
endstream
endobj
7 0 obj
<>stream
xS**T0T0 Bi yA$
endstream
endobj
8 0 obj
<>stream
x+ |
endstream
endobj
9 0 obj
<>stream
xS**T0T0 Bi y8#
endstream
endobj
11 0 obj
<>stream
/GS1 gs
BT
/F6 1 Tf
9.843 0 0 9.843 62.022 725.1588 Tm
0 0 0 rg
0 Tc
0 Tw
[(promise)-384.4(of)-376.5(newer,)-380.7(more)-381.1(precise)-385.5(diagnostic)-382.2(procedures)-382.9(and)]TJ
0 -1.1174 TD
[(more)-283.2(efcacious)-286.1(medical)-283.4(and)-280.9(surgical)-281.9(therapies.)]TJ
1.0137 -1.1116 TD
[(Existing)-257.9(treatment)-256.9(modalities)-262.6(can)-253.3(be)-256.8(more)-260.2(effectively)-259(and)]TJ
-1.0137 -1.1116 TD
[(widely)-273.8(distributed.)-276.2(The)-276.4(failure)-275.2(of)-278.6(Medicare)-273.7(to)-273(reimburse)-278.3(the)]TJ
T*
[(cost)-310.8(of)-307.4(durable)-309.6(medical)-312.2(supplies)-309.4(arises)-313.9(from)-305.1(the)-309.9(inability)-311.2(to)]TJ
0 -1.1174 TD
-.0162 Tc
[(clas)5.9(sify)-282.2(them)-283.5(under)-282.2(a)-1.2(ny)-282.2(ex)5.7(isting)-282.2(b)5.7(enet)-282.4(c)4.6(ategor)5.8(y)-282.2(i)-.1(n)-282.2(t)-.1(he)-277.6(Medi-)]TJ
0 -1.1116 TD
[(care)-398.6(s).2(tatute.)-399.8(T)4.6(his)-397.2(i)-.1(nequi)5.6(ty)-403.2(i)5.6(s)-403(on)5.7(ly)-403.2(r)5.8(ectiable)-398.6(throug)5.7(h)-403.2(f)0(ederal)]TJ
T*
-.0155 Tc
[(legi)6.3(slation)6.4(.)-318.4(The)-317.3(L)-.5(y)6.4(m)-.5(phed)6.4(ema)-317.3(Trea)5.3(tmen)6.4(t)-322(A)-.2(c)5.3(t)-322(\()6.5(LTA\))-316.1(i).6(s)-315.9(a)-.5(n)-316.1(ac-)]TJ
0 -1.1174 TD
-.0162 Tc
[(tive)-191.2(b)0(ill)-196(i)5.6(n)-195.8(the)-197(c)4.6(urrent)5.6(,)-198.2(1)0(1)5.7(5)0(th)-195.8(Con)5.7(gress)-195.6(\(HR)-196.9(930)-190.1(and)-195.8(S)-195.7(4)5.7(97\).)-192.4(The)]TJ
0 -1.1116 TD
0 Tc
[(LTA,)-234.6(when)-231.1(enact)-9.1(ed,)-231.4(will)-236.1(impro)-6.8(ve)-228(covera)-10.1(ge)-233.7(for)-227.9(t)-7(h)0(e)-228(treatm)-10.4(ent)]TJ
T*
[(of)-330.5(lymph)-6.9(edem)-8(a)-324.8(from)-333.9(any)-332.8(cause)-337.1(by)-330.5(amending)-335(the)-332.9(Medic)-8.9(are)]TJ
0 -1.1174 TD
[(statut)-8(e)-198.1(t)0(o)-192.4(create)-207.2(covera)-10.1(ge)-193.4(for)-199.1(compr)-7.9(ession)-203.3(supplie)-8.9(s;)-192.2(while)-203.6(the)]TJ
0 -1.1116 TD
[(bill)-235.2(relate)-10.3(s)-231.3(speci)-8.7(cally)-232.7(to)-232.7(a)-232.6(chang)-7.8(e)-226.9(i)0(n)-232.7(Medic)-8.9(are)-236(law,)-233.5(it)-232.8(would)]TJ
T*
[(set)-309.7(a)-313.3(precedent)-319.9(for)-308.5(Medic)-8.9(aid)-309.9(and)-309.7(privat)-8(e)-307.5(ins)-9(urers)-311.7(to)-307.6(follow)-7.7(.)]TJ
T*
[(As)-290.9(medic)-9.2(al)-285.7(practi)-9.2(tioner)-8(s)-288.9(w)0(e)-292.2(must)-287.8(lend)-293.7(our)-291.3(enthus)-7.7(iastic)-297.1(sup-)]TJ
0 -1.1174 TD
[(port)-378.9(to)-382.5(this)-378.8(legisl)-8(ative)-388.2(proces)-8.7(s)-375.3(o)0(n)-376.6(behal)-8(f)-381.2(o)0(f)-376.5(our)-377.7(numer)-7.9(ous,)]TJ
0 -1.1116 TD
[(unders)-7.5(erved)-290(lymph)-6.9(atic)-283.5(patien)-9.2(ts.)]TJ
1.0137 -1.1116 TD
[(Finally,)-398.4(and)-396.1(most)-397.2(importantly,)-398.6(we)-395.9(must)-397.2(close)-393.7(the)-396.3(infor-)]TJ
-1.0137 -1.1174 TD
[(mation)-210.9(gap)-211.8(so)-209.4(that)-213.2(our)-204.9(patients)-212.9(have)-214.1(access)-212.5(to)-209.7(knowledgeable)]TJ
0 -1.1116 TD
[(and)-344.3(supportive)-346.3(physicians.)-345(Clearly,)-343(this)-344.3(will)-345.5(require)-344.2(curric-)]TJ
T*
[(ular)-195.7(reform,)-196.6(which)-192(can)-195.7(be)-193.4(a)-198.1(slow)-189.5(process.)-197.4(While)-199.3(we)-194.3(await)-193.3(this)]TJ
0 -1.1174 TD
[(much-needed)-369.3(development,)-360.4(we)-367.1(must)-362.7(avail)-359.4(ourselves)-369.1(of)-359.3(the)]TJ
0 -1.1116 TD
[(existing)-298.2(resources.)-304.4(Fortunately,)-300.3(there)-301.7(is)-301.6(a)-296(wealth)-303.8(of)-295.9(didactic)]TJ
T*
[(information)-308.6(available)-308.7(both)-304(in)-307.6(print)-299.5(and)-309.7(in)-301.8(media)-308.7(format.)-306.2(As)]TJ
0 -1.1174 TD
[(one)-378.8(example,)-373.1(the)-379(Lymphatic)-377.8(Research)-382.9(and)-373.1(Education)-376.6(Net-)]TJ
0 -1.1116 TD
[(work)-258.7(\(LE&RN\))-260.8(has)-257.7(sponsored)-258.3(a)-261.4(longstanding)-256.5(virtual)-262.7(lecture)]TJ
T*
[(series)-233.3(in)-232.7(freely)-233.6(accessible,)-233.2(videotaped)-233.6(online)-232.7(format.)]TJ
7.3823 0 0 6.5614 268.3275 444.5857 Tm
(7)Tj
9.843 0 0 9.843 274.2802 440.2204 Tm
(Herein)Tj
-21.5643 -1.1116 TD
[(is)-192.2(contained)-192.2(a)-186.6(wealth)-194.4(of)-186.5(clinical)-191.4(information)-193.4(that)-190.1(can,)-187.6(in)-192.4(many)]TJ
0 -1.1174 TD
[(ways,)-291.9(take)-289.1(the)-286.8(place)-291.4(of)-290.1(the)-286.8(material)-296.1(that)-288(is)-284.4(omitted)-292.7(from)-287.8(the)]TJ
0 -1.1116 TD
[(current,)-284.2(formal)-279.8(training)-286.8(process)-280.3(for)-279.7(clinical)-289.3(specialists.)]TJ
26.5177 32.2889 TD
[(Creating)-358(a)-359.4(b)-6.9(e)-13.8(t)-12.7(t)-7(e)-13.8(r)-358.2(w)-13.5(o)-6.9(r)-12.6(l)-12.7(d)-358.2(f)-12.6(o)-6.9(r)-363.9(l)-7(y)-12.6(m)-8.1(p)-12.6(h)-6.9(a)-13.8(t)-12.7(i)-7(c)-359.4(p)-12.6(a)-13.8(t)-7(i)-12.7(e)-8(n)-12.6(t)-7(s)-363.8(i)-12.7(s)-358(n)-12.6(o)-6.9(t)-364.1(a)-8(n)]TJ
-1.0137 -1.1174 TD
.0117 Tc
[(idl)4.7(e)-192.1(d)4.8(r)-.9(eam.)-187.6(The)-186.4(t)-1(o)4.8(o)-.9(l)4.7(s)-190.8(alread)4.8(y)-191(e)3.7(xis)5(t)-1(.)-187.6(I)-.9(n)-185.2(a)-186.4(fut)4.7(ure)-186.4(wo)4.8(rl)4.7(d)-191(o)4.8(f)-191(i)-1(d)4.8(e)-2.1(al)]TJ
0 -1.1116 TD
.0095 Tc
[(m)-4.3(e)1.5(dica)-4.3(l)-274(p)2.6(ra)-4.3(ctic)-4.3(e,)-276.2(c)-4.3(l)2.5(inic)-4.3(ia)-4.3(ns)-279.4(will)-274(re)-4.3(ce)-4.3(ive)-275(t)-3.2(he)-275(sa)-4.3(me)-275(e)-4.3(x)2.6(posure)]TJ
T*
.0122 Tc
[(to)-507.3(th)5.3(e)-508.4(l)-.5(y)5.3(m)-1.6(p)5.3(h)-.4(atic)-508.4(s)5.5(y)-.4(st)5.2(em)-502.7(that)-507.4(th)5.3(ey)-507.3(curr)5.4(en)5.3(tly)-507.3(r)5.4(e)-1.6(cei)5.2(v)-.4(e)-508.4(f)-.4(o)5.3(r)]TJ
T*
.0124 Tc
[(car)5.6(di)5.4(ac,)-267.5(r)-.2(enal,)-261.7(e)-1.4(nd)5.5(ocri)5.4(ne,)-261.7(a)-1.4(n)5.5(d)-265.2(ot)5.4(her)-265.1(b)5.5(od)5.5(il)5.4(y)-265.2(fun)5.5(ct)5.4(ion)5.5(s)0(.)-261.7(I)-.2(f)-265.1(n)-.2(o)5.5(t)]TJ
0 -1.1174 TD
.0071 Tc
[(t)-5.6(o)-5.5(da)-6.7(y,)-353.4(t)-5.6(h)-5.5(en)-356.9(to)-5.5(mo)-5.5(r)-5.5(r).3(o)-5.5(w)-.6(,)-353.4(w)-6.4(e)-352.3(m)-6.7(us)-5.3(t)-357(b).2(e)-358(a)-.9(b)-5.5(l).1(e)-358(t).1(o)-356.9(e)-6.7(ns)-5.3(ur)-5.5(e)-358(t).1(h)-5.5(a)-.9(t)-357(m)-1(y)]TJ
0 -1.1116 TD
.0116 Tc
[(lymph)4.7(a)-2.2(t)4.6(i)-1.1(c)-301.7(p)-1(atient)4.6(,)-302.9(a)-2.2(nd)-300.5(ot)4.6(hers)-300.3(lik)4.7(e)-307.4(h)4.7(im,)-302.9(w)-1.9(i)4.6(l)-1.1(l)-306.4(r)4.8(ecei)4.6(ve)-301.7(the)-301.7(r)-1(e-)]TJ
T*
[(qui)4.7(red)-260.1(h)4.8(igh)-254.3(l)-1(evel)-260.2(med)4.8(i)-1(cal)-254.5(car)4.9(e)-261.3(w)4(it)4.7(ho)4.8(ut)-254.5(the)-255.5(n)-.9(eed)-254.3(f)-.9(o)4.8(r)-260.1(a)-255.5(3)-.9(,00)4.8(0)]TJ
0 -1.1174 TD
.0131 Tc
[(mi)6.1(le)-277.1(jo)6.2(urn)6.2(ey)6.2(.)]TJ
/F9 1 Tf
8.9663 0 0 8.9663 313.0582 612.0565 Tm
0 Tc
(References)Tj
/F6 1 Tf
9.2951 0 0 9.2951 313.0582 596.0125 Tm
[(1.)-500.4(Aselli)-473.7(G.)-465.3(De)-469.6(Lactibus)-473(Sive)-464.5(Lacteis)-470.9(Venis.)-468.7(Milan:)-472.3(JB)-467.7(Bi-)]TJ
1.2503 -1.1284 TD
[(dellius;)-337.7(1627.)]TJ
-1.2503 -1.1223 TD
[(2.)-500.4(Choi)-474.4(I,)-472.2(Lee)-474.3(S,)-472.8(Hong)-471.8(YK.)-467.1(The)-476.2(new)-469.7(era)-474.7(of)-472.2(the)-473.7(lymphatic)]TJ
1.2503 -1.1284 TD
[(system:)-367.8(No)-361.7(longer)-366.7(secondary)-363(to)-365.7(the)-363.9(blood)-360(vascular)-368.4(system.)]TJ
0 -1.1223 TD
[(Cold)-334.1(Spring)-334.9(Harb)-338(Perspect)-334.7(Med)-333.3(2012;2:a006445.)]TJ
-1.2503 -1.1284 TD
[(3.)-500.4(Hall)-359(JE.)-355.1(Textbook)-360.4(of)-350.3(Medical)-359.4(Physiology.)-356.2(13th)-353.8(Edition)-361(ed.)]TJ
1.2503 -1.1223 TD
[(Philadelphia:)-337.8(Saunders;)-336.7(2015.)]TJ
-1.2503 -1.1284 TD
[(4.)-500.4(Rockson)-289.7(SG,)-285.4(Granger)-290.1(DN,)-290.2(Skeff)-286.9(KM,)-287.9(Chaite)-287.4(W.)-285.1(Lymphatic)]TJ
1.2503 -1.1223 TD
[(biology)-426.8(and)-419.4(disease:)-425.6(Is)-422.6(it)-426.1(being)-419.1(taught?)-429.1(Who)-419.5(is)-425.8(listening?)]TJ
0 -1.1284 TD
[(Lymphat)-335.5(Res)-337.9(Biol)-333.6(2004;2:8695.)]TJ
-1.2503 -1.1223 TD
[(5.)-500.4(Brayton)-249.6(KM,)-245.2(Hirsch)-245.4(AT,)-247.8(PJ)-246.3(OB,)-244.6(Cheville)-244.4(A,)-245.8(Karaca-Mandic)]TJ
1.2503 -1.1284 TD
[(P,)-588.6(Rockson)-588.6(SG.)-590.4(Lymphedema)-594.5(prevalence)-591.5(and)-590.2(treatment)]TJ
0 -1.1223 TD
[(benets)-413.4(in)-408.4(cancer:)-416(Impact)-413.2(of)-411.3(a)-406.9(therapeutic)-415.5(intervention)-412.7(on)]TJ
0 -1.1284 TD
[(health)-337.5(outcomes)-337.1(and)-334(costs.)-332(PLoS)-337.6(One)-335.6(2014;9:e114597.)]TJ
-1.2503 -1.1223 TD
[(6.)-500.4(Karaca-Mandic)-343.1(P,)-338.6(Hirsch)-336.9(AT,)-339.3(Rockson)-332.4(SG,)-340.3(Ridner)-334.9(SH.)-334.2(the)]TJ
1.2503 -1.1284 TD
[(cutaneous,)-348(net)-339.5(clinical,)-347(and)-340.1(health)-343.6(economic)-342.1(benets)-340.2(of)-344.2(ad-)]TJ
0 -1.1223 TD
[(vanced)-617.3(pneumatic)-616.2(compression)-619.5(devices)-616(in)-615.7(patients)-616.9(with)]TJ
0 -1.1284 TD
[(lymphedema.)-342.1(JAMA)-331.5(Dermatol)-335.2(2015;151:11871193.)]TJ
-1.2503 -1.1223 TD
[(7.)-500.4(LE&RN)-339.8(Symposium)-331.2(series.)-338.7(\(Accessed)-337.4(August)-336.5(27,)-329.7(2017\).)]TJ
/F9 1 Tf
8.9663 0 0 8.9663 62.022 749.6502 Tm
(316)Tj
49.2744 0 TD
(EDITORIAL)Tj
ET
endstream
endobj
19 0 obj
<>stream
8;X]O>EqN@%''O_@%e@?J;%+8(9e>X=MR6S?i^YgA3=].HDXF.R$lIL@"pJ+EP(%0
b]6ajmNZn*!='OQZeQ^Y*,=]?C.B+\Ulg9dhD*"iC[;*=3`oP1[!S^)?1)IZ4dup`
E1r!/,*0[*9.aFIR2&b-C#soRZ7Dl%MLY\.?d>Mn
6%Q2oYfNRF$$+ON<+]RUJmC0InDZ4OTs0S!saG>GGKUlQ*Q?45:CI&4J'_2j$XKrcYp0n+Xl_nU*O(
l[$6Nn+Z_Nq0]s7hs]`XX1nZ8&94a\~>
endstream
endobj
20 0 obj
<>stream
8;Z\7#nFiq%-.@0b]fpZD$;45KKrP3Bnlu62C*AE3uT:diIdtu"^$5*IQf!naf6@3
7QTFefDhUUJ$Ur:^gY?M?1bGM>H*?e=TF9%"n[6fFt3oVa0CB9F0lX;4n7;OA@^^>
XLU$tM#'9L2IOqS(+ddnH"!#q@i?obJ;>+t)%6=QeEDQ#Vm3(Q85\HidU:c+*9S-l
FX2sP#&Kmq)1l3S7UijV\[aM0:gY^lqlj7UnUPfo,Qo2S\`c\ugHZ28Z[=mMC65
d`nT-@Xt-J<@$UR;1;'rKDcu1[d\UJ7dc_.YV^-$"]7#G\fZS';Y0J!U,Pa%RlPqk
$,qCt;1?JuS9lTm>W#?V?W)KF7M?P#%U$dca$S&fhP8[26).rkJbF=,HBB:tnI:cB
nJ_Hi14W+~>
endstream
endobj
12 0 obj
<>stream
8;Z]!;%A44$q#CA$g'M!`Ya9&C#,XrRf#>\d,;hH!?u'-;?ee$P!$o;8k3nY:bk>e^?';WSd5j]@Oi,.`=MIXXG.4,8BPcgLPb'l+W4A
SC^W"k&K"Zm5dDu[>e`g$Sg&?3i1#sjLguJK($%r@UP^;H.hi8VrYLA;`!^MVc+Lf
$ePs+Jj">ooV!=2Y#Sk7[:\ES2*D!Q9PC+0BB$G0[Wrtlk+?A)j%s(M8<27;o85_2
Lt6?%mgjs\63n`f&4-ZuIi\[lM26O!~>
endstream
endobj
24 0 obj
<>
endobj
25 0 obj
<>stream
HlUێ6}߯#]K_
i-h\EĵȒ!Jqk+=Ñw1p̜՛js7?o^6jQVVn2VVJ*6uT7Y1 k;|?5